Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin dose-effect study during cesarean section in non-scarred versus scarred uterus
ChiCTR1900023474Phase 4Recruiting
- Sponsor
- Jiaxing Maternity and Child Health Care Hospital
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxytocin in uterine atony (2 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoints: Oxytocin dose, Estimated blood loss and 3 more. Started Jun 2019; status: recruiting.
02
Drugs
oxytocin
03
Conditions
uterine atony
Beyond the preview
Go deeper on ChiCTR1900023474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023474.